Articles from Medical Microinstruments, Inc.
First-in-human case marks clinical debut of NanoWrist® dissection tools and Synaptix™ digital surgery platform, enabling greater robotic precision across more of the microsurgical procedure
By Medical Microinstruments, Inc. · Via GlobeNewswire · July 10, 2025

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced the company will participate in the 43rd Annual J.P. Morgan Healthcare Conference, taking place in San Francisco from January 13-16, 2025. This marks MMI’s third consecutive year presenting in the private company track, underscoring sustained interest in groundbreaking advancements and innovations within the field of open surgery.
By Medical Microinstruments, Inc. · Via Business Wire · January 8, 2025

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced its Symani® Surgical System has been named to the TIME Best Inventions 2024 list. Symani was one of five inventions featured in the “Robotics” category and joined several other groundbreaking healthcare innovations across the full list.
By Medical Microinstruments, Inc. · Via Business Wire · October 30, 2024

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced the completion of a preclinical study that demonstrated the feasibility of the Symani® Surgical System in neurosurgical procedures. Adnan Siddiqui, M.D., Ph.D., Chief Executive Officer and Chief Medical Officer of the Jacobs Institute and Vice Chair and Professor of Neurosurgery in the Jacobs School of Medicine and Biomedical Sciences, successfully repaired a blood vessel in the brain in an animal model using the Symani Surgical System, the first such robotic-assisted microsurgery demonstration in the brain.
By Medical Microinstruments, Inc. · Via Business Wire · August 1, 2024

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced milestones across two continents that increase the global reach of the Symani® Surgical System. The company announced:
By Medical Microinstruments, Inc. · Via Business Wire · July 9, 2024

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced the completion of its first clinical cases in the United States using the Symani® Surgical System. Both robotic-assisted microsurgical procedures were performed at Penn Medicine, Penn Presbyterian Medical Center, as a collaborative effort between the Department of Orthopaedic Surgery and the Department of Surgery’s, Division of Plastic Surgery.
By Medical Microinstruments, Inc. · Via Business Wire · May 1, 2024

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that its Symani® Surgical System is now commercially available in the United States. The U.S. Food and Drug Administration (FDA) granted De Novo Classification to the robotic system for soft tissue manipulation to perform microsurgery, a highly specialized technique that involves reconnecting tiny vessels to restore blood flow or redirect fluid during reconstruction or repair.
By Medical Microinstruments, Inc. · Via Business Wire · April 8, 2024

MMI, (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it will continue its global momentum with two distribution agreements covering nearly a dozen countries in the Asia Pacific (APAC) region. The first partnership, with Device Technologies, will help to introduce the Symani Surgical System to Hong Kong, Singapore, Vietnam, Malaysia, Indonesia, Thailand, Philippines, Macau, and New Zealand, upon applicable regulatory approvals, as well as Australia, where it recently received approval from the Therapeutic Goods Administration (TGA). The other partnership, with TRM Korea, will facilitate the system’s entry into South Korea upon regulatory approval and will introduce microsurgical robotic technology to interested surgeons and hospitals.
By Medical Microinstruments, Inc. · Via Business Wire · October 17, 2023

MMI (Medical Microinstruments, Inc.), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 9-12, 2023.
By Medical Microinstruments, Inc. · Via Business Wire · January 4, 2023

Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing. Deerfield Management led the round with participation from new investors, RA Capital Management and Biostar Capital, as well as existing investors, Andera Partners, Fountain Healthcare Partners, Panakès Partners and Sambatech. The company also announced the addition of three new members to its board of directors.
By Medical Microinstruments, Inc. · Via Business Wire · July 20, 2022